Towards Healthcare
Diagnostic Testing Market to Reach USD 274.53 Bn by 2034

Diagnostic Testing Market 2025 Driven by Early Diagnosis

Market insights predict, the diagnostic testing industry is expected to grow from USD 203.3 billion in 2024 to USD 274.53 billion by 2034, driven by a CAGR of 3.04%. The rising prevalence of chronic and infectious diseases is estimated to drive the growth of the market. North America led the global market owing to its advanced healthcare infrastructure in the region.

Content

  • Insight Code: 6196
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The diagnostic testing market stands at USD 209.48 billion in 2025 and is expected to reach USD 274.53 billion by 2034, growing at a CAGR of 3.04% from 2024 to 2034.

North America is leading the diagnostic testing market share 40% due to the rising demand for personalized medicines, rising government initiatives, and the presence of key players.

Some key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation (Cepheid, Beckman Coulter), and Thermo Fisher Scientific, among others.

Key trends include telehealth and remote monitoring, increasing investments, and the adoption of inorganic growth strategies.

Association for Diagnostics & Laboratory Medicine (ADLM), Personalized Medicine Coalition, American Clinical Laboratory Association, Government of Canada, BIVDA - The British In Vitro Diagnostic Association, Food and Drug Administration, Association for Molecular Pathology, clinicaltrials.gov, and GOV.UK, among others.
Any Questions